Skeletal muscle-targeted peptide MSP
Selected Variant
GTR19065961-01
Size: 50 mg
The MSP peptide (ASSLNIA) is a muscle-targeting ligand for selective delivery in research. It is utilized in both in vitro and in vivo studies to investigate cardiac and skeletal muscle pathologies, including muscular dystrophy and heart failure models.
Product Specifications
Field of Research
Musculoskeletal & Connective Tissue Research
Molecular Weight
674.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog